a long-term strategy of low-intensity warfarin (target INR, 1.5-2.0) was significantly more effective than placebo for preventing VTE recurrence (Journal Watch Cardiology Apr 18 2003). In a new ...
After enrollment, patients received either conventional warfarin (target INR, 2.0-3.0) or low-intensity warfarin (target INR, 1.5-1.9). During an average follow-up of 2.4 years, recurrent VTE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback